ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

2-スルホこはく酸1,4-ビス(2-エチルヘキシル)

Docusate

HCID 11339
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
10041-19-7
標準SMILES
CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O
InChIKey
HNSDLXPSAYFUHK-UHFFFAOYSA-N
分子式
C20H38O7S
平均分子量
422.6 g/mol
単同位体質量
422.23382472

概要

1,4-bis(2-ethylhexyl) sulfosuccinate is an organosulfonic acid and a diester.

名称と識別子

優先名称
Docusate
IUPAC
1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonic acid
現地名
2-スルホこはく酸1,4-ビス(2-エチルヘキシル)
英語名
1,4-bis(2-ethylhexyl) 2-sulphosuccinate
分子式
C20H38O7S
分子量
422.58

名称と別名

DOCUSATEDocusate hydrogen10041-19-7Spolion 8DioctoDioctylsulfosuccinsaeureDocusatesDIOCTYLSULFOSUCCINATEM7P27195AGDTXSID1044279Butanedioic acid, 2-sulfo-, 1,4-bis(2-ethylhexyl) ester1,4-Bis(2-ethylhexyloxy)-1,4-dioxo-2-butansulfonsaeure [IUPAC]
名称をさらに表示
スルホこはく酸1,4-ジ(2-エチルヘキシル)スルホこはく酸ビス(2-エチルヘキシル)水素ドクサート2-(ヒドロキシスルホニル)こはく酸ビス(2-エチルヘキシル)2-スルホブタン二酸1,4-ジ(2-エチルヘキシル)スルホこはく酸1,4-ビス(2-エチルヘキシル)2-スルホこはく酸1,4-ビス(2-エチルヘキシル)ジオクチルスルホサクシネート2-スルホブタン二酸1,4-ビス(2-エチルヘキシル)1,4-ビス[(2-エチルヘキシル)オキシ]-1,4-ジオキソブタン-2-スルホン酸ビス(2-エチルヘキシル)スルホスクシネート1,4-ビス(2-エチルヘキシルオキシ)-1,4-ジオキソブタン-2-スルホン酸Dioctyl Sulfosuccinic AcidBis(2-ethylhexyl)sulfosuccinateBIS(2-ETHYLHEXYL)SULPHOSUCCINATESULPHOSUCCINICACID,BIS(2-ETHYLHEXYL)ESTERSulfosuccinic acid 1,4-bis(2-ethylhexyl) esterButanedioic acid,sulfo-,1,4-bis(2-ethylhexyl)esterButanedioic acid, sulfo-, 1,4-bis(2-ethylhexyl) ester
1,4-Bis(2-ethylhexyloxy)-1,4-dioxo-2-butansulfonsaeure (IUPAC)DocQLaceSulfosuccinate, DioctylRefChem:55059DTXCID90242791,4-bis(2-ethylhexoxy)-1-oxo-4-oxoniumylidenebutane-2-sulfonate233-124-01,4-Bis(2-ethylhexyl) 2-sulphosuccinate

物性

構造計算による物性

XLogP
5.1
極性表面積
115 Ų
水素結合供与体数
1
水素結合受容体数
7
回転可能結合数
18
重原子数
28
形式電荷
0
複雑度
539

実験および物理化学的性質

Chemical Classes · 3 件

Other Uses -> Emulsifiers/Surfactants

Other Uses -> Emulsifiers/Surfactants

Industrial compound

DrugsPharmaceuticals
LipidsFatty Acyls [FA] -> Fatty esters [FA07] -> Wax monoesters [FA0701]
SolubilitySoluble
Human DrugsBreast Feeding; Lactation; Milk, Human; Gastrointestinal Agents; Laxatives; Surface-Active Agents
Melting Point153-157
Collision Cross Section206.1 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID8022959]

物理化学的性質

比重(密度)
1.096 · 1.096±0.06 g/cm3(Predicted)
酸解離定数(Pka)
0.08 · 0.08±0.50(Predicted)
EPAの化学物質情報
1 · Butanedioic acid, sulfo-, 1,4-bis(2-ethylhexyl) ester (10041-19-7)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

Regulatory InformationChemical: Butanedioic acid, sulfo-, 1,4-bis(2-ethylhexyl) ester
Hazards Summary · 2 件

Anionic and nonionic soaps and detergents may be toxic if ingested--may cause vomiting and diarrhea; [HSDB]

No evidence of teratogenicity in rats or humans; One case report of hypomagnesemia associated with maternal excessive/chronic use of laxatives by the mother; [REPROTOX] See Docusate sodium.

毒性情報

Hepatotoxicity · 1 件

Docusate has not been linked to elevations in serum enzyme levels during treatment, although there have been few published studies of its effects of liver tests. There have been no cases of clinically apparent liver injury attributable to docusate published in the literature and, thus, significant liver injury from docusate must be exceedingly rare, if it occurs at all.

Adverse Effects · 1 件

The adverse effects of docusate are generally mild. Anorexia, diarrhea, and vomiting are usually associated with excess doses of docusate medication. Some people may experience abdominal cramping or, rarely, develop a rash as adverse reactions to docusate.

Toxicity Summary · 1 件

Docusate has a well-documented safety and tolerability profile and has been in use in the United States since the 1950s. Animal studies have demonstrated that docusate sodium ear drops can cause significant ototoxicity. Therefore, docusate ear drops should be avoided in patients with tympanic membrane perforation.

Drug Induced Liver Injury · 5 件

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Docusate

DILI Negative

oral

DOI:10.1016/j.drudis.2019.09.022

化学と産業

薬理情報

Pharmacodynamics · 1 件

Docusate sodium is a laxative and an anionic detergent that supposedly promotes incorporation of water and fats into stool through a reduction in surface tension, resulting in softer fecal mass. Docusate's onset of action is 6-72 hours orally and 2-15 minutes rectally. The effects of docusate are thought to be exerted locally in the jejunum.

Mechanism of Action · 1 件

Recent studies suggest that docusate's mechanism of action is due largely to it's surfactant effect in the intestines, which allow fat and water into the feces to soften the stool. Docusate’s mechanism of action was investigated in 1985 on healthy patients. Docusate was added directly to the jejunum based on calculated concentrations of docusate in the jejunum. At this concentration, there was an increase in secretion of water, sodium, chloride, and potassium as well as a decrease in absorption of glucose and bicarbonate. Based on in vitro data, the authors suggested this effect was due to an increase in intracellular cyclic AMP either directly through docusate or E series prostaglandins.

MeSH Pharmacological Classification · 1 件

Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics.

Absorption, Distribution and Excretion · 2 件

Docusate is not absorbed systemically. As the actions of docusate are local and it is not absorbed, the pharmacokinetic parameters are not available.

If docusate is systemically absorbed, it undergoes biliary excretion.

用途と製造

Uses · 5 件

Used as chemical intermediate, surface-active agent (prolongs pyrethroid activity), and sludge remover (crude oil tanks); [HSDB]

Petroleum Production and Refining [Category: Industry]

関連反応

2 件
反応記録を作成
HRID 1517230 の反応式
HRID 1517230反応物として
HRID 2403135 の反応式
HRID 2403135反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
10041-19-7、2373-23-1
PubChem CID
11339
DTXSID
DTXSID1044279
ChEMBL
CHEMBL1477036
ChEBI
CHEBI:534
UNII
M7P27195AG
EC Number
233-124-0
Nikkaji
J8.977J
Effects During Pregnancy and Lactation
◉ Summary of Use during Lactation
EPA Human Health Benchmarks for Pharmaceuticals · 6 件

Docusate

1.2

4.9

Dosage for adults and children 12 years and older is 1-6 soft gels (each containing 50 mg docusate sodium), daily

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 50 mg/day, Lowest Therapeutic Dose (LTD): 0.6 mg/kg-day, and Screening Dose: 0.0002 mg/kg-day.

7-Nov-19

安全データ

tsca
TSCA listed
hs_code
2914509090

Surfactant, wetting agent, and solubilizer used in drugs, cosmetics, and foods; Has been used as a laxative and cerumenolytic; [ChemIDplus]

CHEMICAL INTERMEDIATE; SURFACE ACTING AGENT USED TO PROLONG PYRETHROID INSECTICIDE ACTIVITY; USED IN SLUDGE REMOVAL

Use (kg; approx.) in Germany (2009): >100

U.S. Exports(1986) No Data
U.S. Imports(1986) No Data
U.S. Production(1986) No Data
General Manufacturing Information · 3 件

Butanedioic acid, 2-sulfo-, 1,4-bis(2-ethylhexyl) ester: ACTIVE

SURFACE-ACTIVE AGENTS DIOCTYL SULFOSUCCINATE ADDED TO PYRETHROID FUMIGANTS PROLONGED INSECTICIDAL ACTIVITY.

SLUDGE ACCUMULATED ON CRUDE OIL TANK BOTTOM WAS DISSOLVED WITH CRUDE OIL CONTAINING DIOCTYL SULFOSUCCINATE.

応用分野

使用Stool softener.